Charles River Laboratories International Interest Expense | CRL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
-22.6 M	-16.5 M	137 M	59.3 M	73.9 M	86.4 M	60.9 M	63.8 M	29.8 M	27.7 M	15.1 M	12 M	21 M	33.3 M	42.6 M	35.3 M	21.7 M	22.3 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
137 M	-22.6 M	39 M

Quarterly Interest Expense Charles River Laboratories International

2026-Q3	2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q4	2010-Q3	2010-Q2
-4.41 M	-37.4 M	-124 M	12.1 M	-22.6 M	154 K	-12.2 M	-22.7 M	2.59 M	-2.24 M	5.83 M	108 M	-6.26 M	-2.66 M	-3.28 M	116 M	-16.6 M	-39.8 M	-28.6 M	2.07 M	-16.2 M	5.96 M	-27.7 M	76.6 M	21.2 M	26.3 M	-24.1 M	20.5 M	-14.3 M	-213 K	6.31 M	-10.8 M	5.91 M	12 M	6.12 M	13.8 M	6.41 M	2.47 M	15.1 M	1.7 M	1.02 M	5.02 M	4.03 M	1.26 M	1.39 M	8.67 M	-8.31 M	1.85 M	331 K	2.67 M	5.88 M	1.07 M	4.06 M	967 K	1.07 M	-684 K	-892 K	-1.35 M	-344 K	681 K	-747 K	-408 K	63 K	1.37 M	-1.65 M	-734 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
116 M	-124 M	1.16 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Myriad Genetics MYGN	800 K	$ 5.97	-5.17 %	$ 553 M	USA
ENDRA Life Sciences NDRA	-691 K	$ 4.73	-5.49 %	$ 3.72 M	USA
NeoGenomics NEO	296 K	$ 16.85	2.18 %	$ 2.16 B	USA
OPKO Health OPK	207 M	$ 1.72	-1.71 %	$ 1.29 B	USA
Pacific Biosciences of California PACB	14.8 M	$ 2.3	-5.35 %	$ 690 M	USA
Neogen Corporation NEOG	24.1 M	$ 11.75	0.6 %	$ 2.56 B	USA
Precipio PRPO	839 K	$ 18.95	2.02 %	$ 30.4 M	USA
Personalis PSNL	205 K	$ 15.76	1.32 %	$ 1.41 B	USA
Sotera Health Company SHC	8.55 M	$ 16.01	0.88 %	$ 4.55 B	USA
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	17.6 K	-	-	$ 7.1 B	Australia
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
National Research Corporation NRC	-95 K	$ 25.62	0.55 %	$ 573 M	USA
Twist Bioscience Corporation TWST	-903 K	$ 120.83	0.18 %	$ 7.23 B	USA
Organovo Holdings ONVO	25 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	11.2 K	-	-16.95 %	$ 1.54 M	USA
PerkinElmer PKI	-38 M	-	-0.91 %	$ 14.7 B	USA
Soleno Therapeutics SLNO	2.58 M	-	-	$ 2.69 B	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Quest Diagnostics Incorporated DGX	26 M	$ 257.93	1.18 %	$ 28.6 B	USA
Danaher Corporation DHR	-222 M	$ 230.45	1.76 %	$ 164 B	USA
IDEXX Laboratories IDXX	41.6 M	$ 676.3	0.83 %	$ 54.4 B	USA
Illumina ILMN	340 M	$ 213.05	2.43 %	$ 33 B	USA
Lantheus Holdings LNTH	31.3 M	$ 100.61	-0.09 %	$ 6.79 B	USA
Accelerate Diagnostics AXDX	-595 K	-	-61.36 %	$ 2.46 M	USA
Medpace Holdings MEDP	-5.34 M	$ 653.24	2.88 %	$ 18.8 B	USA
Mettler-Toledo International MTD	68.5 M	$ 1 722.36	2.64 %	$ 35.5 B	Schweiz
Natera NTRA	4.07 M	$ 319.38	-12.2 %	$ 43.7 B	USA
Koninklijke Philips N.V. PHG	288 M	$ 30.33	-0.57 %	$ 28.8 B	Niderland
QIAGEN N.V. QGEN	-6.65 M	$ 50.36	-0.98 %	$ 10.9 B	Niderland
RadNet RDNT	32.1 M	$ 75.83	-2.79 %	$ 5.7 B	USA
Senseonics Holdings SENS	-23 K	$ 8.58	7.38 %	$ 358 M	USA
T2 Biosystems TTOO	-495 K	-	-39.35 %	$ 313 K	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Neuronetics STIM	716 K	$ 2.17	-10.91 %	$ 143 M	USA
Thermo Fisher Scientific TMO	-12 M	$ 694.85	2.62 %	$ 262 B	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Trinity Biotech plc TRIB	6.75 M	$ 6.07	2.97 %	$ 2.18 B	Irlanda
VolitionRx Limited VNRX	-1.76 M	$ 0.2	3.39 %	$ 25.2 M	Singapore
Waters Corporation WAT	14.3 M	$ 458.04	1.06 %	$ 27.3 B	USA
Exagen XGN	2.34 M	$ 5.79	-23.82 %	$ 125 M	USA
Guardant Health GH	-10.5 M	$ 151.28	-1.4 %	$ 19 B	USA
Laboratory Corporation of America Holdings LH	224 M	$ 366.98	1.02 %	$ 30.5 B	USA